RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 73 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q1 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $131,000 | +29.7% | 14,567 | -22.7% | 0.00% | – |
| Q2 2016 | $101,000 | +274.1% | 18,845 | +216.7% | 0.00% | – |
| Q1 2016 | $27,000 | +68.8% | 5,951 | +100.0% | 0.00% | – |
| Q4 2015 | $16,000 | -5.9% | 2,975 | +3.7% | 0.00% | – |
| Q3 2015 | $17,000 | -52.8% | 2,870 | +24.1% | 0.00% | – |
| Q2 2015 | $36,000 | +56.5% | 2,313 | +9.7% | 0.00% | – |
| Q1 2015 | $23,000 | +15.0% | 2,109 | +6.6% | 0.00% | – |
| Q4 2014 | $20,000 | +5.3% | 1,979 | 0.0% | 0.00% | – |
| Q3 2014 | $19,000 | -17.4% | 1,979 | 0.0% | 0.00% | – |
| Q2 2014 | $23,000 | +15.0% | 1,979 | 0.0% | 0.00% | – |
| Q1 2014 | $20,000 | -23.1% | 1,979 | 0.0% | 0.00% | – |
| Q4 2013 | $26,000 | -13.3% | 1,979 | 0.0% | 0.00% | – |
| Q3 2013 | $30,000 | +57.9% | 1,979 | 0.0% | 0.00% | – |
| Q2 2013 | $19,000 | – | 1,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |